Scholar Rock director reports 289K-share purchase
Scholar Rock Holding Corp (SRRK) director Srinivas Akkaraju reported purchases totaling 289,470 common shares held by Samsara BioCapital, L.P. and Samsara Opportunity Fund, L.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Scholar Rock Holding Corp (SRRK) director Srinivas Akkaraju reported purchases totaling 289,470 common shares held by Samsara BioCapital, L.P. and Samsara Opportunity Fund, L.P. The purchases occurred October 23 and October 26, 2026, at reported weighted-average prices of $41.31, $41.82 and $41.59 per share. No Rule 10b5-1 plan is reported. A separate entry lists 27,971 common shares held directly as of October 23, 2026.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 289,470 shares
Net Buy
7 txns
Insider
AKKARAJU SRINIVAS
Role
Director
Bought
289,470 shs ($12.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F6, F3 | 48,988 | $41.59 | $2.04M |
| Purchase | Common Stock F6, F4 | 97,982 | $41.59 | $4.08M |
| Purchase | Common Stock F1, F2, F3 | 47,000 | $41.31 | $1.94M |
| Purchase | Common Stock F1, F4 | 94,000 | $41.31 | $3.88M |
| Purchase | Common Stock F5, F3 | 500 | $41.82 | $21K |
| Purchase | Common Stock F5, F4 | 1,000 | $41.82 | $42K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 6,380,517 shares (Indirect, By Samsara BioCapital, L.P.);
Common Stock — 723,020 shares (Indirect, By Samsara Opportunity Fund, L.P.);
Common Stock — 27,971 shares (Direct)
Footnotes (6)
- F1. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $40.77 to $41.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
- F2. The shares held by Samsara BioCapital LP ("Samsara LP") prior to the reported transaction reflect the disposition of 83,585 shares in which the Reporting Person had no pecuniary interest. The disposition of such shares by Samsara LP did not involve a change in the Reporting Person's beneficial ownership of such shares and, accordingly, was exempt from reporting under Section 16.
- F3. Securities are directly held by Samsara LP. Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
- F4. Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
- F5. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $41.78 to $41.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $41.15 to $41.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
Key Figures
Shares purchased through funds: 289,470 shares
Common shares purchased: 47,000 shares
Common shares purchased: 94,000 shares
+5 more
8 metrics
Shares purchased through funds
289,470 shares
Six purchases reported for October 23 and October 26, 2026
Common shares purchased
47,000 shares
Samsara BioCapital, L.P.; October 23, 2026; $41.31 weighted-average price per share
Common shares purchased
94,000 shares
Samsara Opportunity Fund, L.P.; October 23, 2026; $41.31 weighted-average price per share
Common shares purchased
500 shares
Samsara BioCapital, L.P.; October 23, 2026; $41.82 weighted-average price per share
Common shares purchased
1,000 shares
Samsara Opportunity Fund, L.P.; October 23, 2026; $41.82 weighted-average price per share
Common shares purchased
48,988 shares
Samsara BioCapital, L.P.; October 26, 2026; $41.59 weighted-average price per share
Common shares purchased
97,982 shares
Samsara Opportunity Fund, L.P.; October 26, 2026; $41.59 weighted-average price per share
Common shares held directly
27,971 shares
As of October 23, 2026
Key Terms
weighted average price, pecuniary interest, beneficially own, voting and investment power
4 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest regulatory
"except to the extent of his pecuniary interest therein"
beneficially own regulatory
"may be deemed to beneficially own the securities held by Samsara LP"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
voting and investment power regulatory
"The Reporting Person has voting and investment power over the securities"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
